Opthea’s Phase 2b Wet AMD Clinical Trial Reaches Mid-Way Point of Patient Recruitment
Opthea Recruits 176th Patient and On-Track to Report Primary Data Analysis Early 2020
Opthea Limited (ASX:OPT), a late stage biopharmaceutical company developing nove...
Continue Reading →
